Remove Doctors Remove Hospitals Remove Treatment
article thumbnail

Sloane’s 1st ASO treatment

KIF1A

Fortunately, Sloane does not currently have epilepsy, and Megan hopes this treatment will prevent it’s onset as her disease progresses. On the day of the treatment, they checked into the hospital where Sloane was administered sedation medication. The post Sloane’s 1st ASO treatment appeared first on KIF1A.

article thumbnail

Immuno-oncology innovations redefining cancer treatment in 2024

Drug Target Review

What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? Immuno-oncology, notably through checkpoint inhibitors, has significantly reshaped cancer treatment over the past decade.

Treatment 122
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK’s NICE supports CAR-T for young people with leukaemia

Drug Discovery World

The treatment becomes only the second CAR-T cell therapy to secure routine funding for use in the NHS, and the only one for treating ALL in children and young adults under 26 years old. It is approved in cancers that are refractory, in relapse post-transplant or in second or later relapse.

Doctors 130
article thumbnail

Researchers design genetic therapy to prevent brain deterioration

Drug Discovery World

A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified potential treatments for children with rare genetic conditions. Doctors believed the calcium deposits were non-specific signs of brain damage, but this research challenges this view.

Therapies 147
article thumbnail

Innovent updates ESMO 2024 on mAbs in solid tumours

Drug Discovery World

of the participants had previously undergone five or more systemic treatment regimens. A total of 368 participants with advanced solid tumours were enrolled, including 178 with breast cancer, 92 with ovarian cancer, 38 with colorectal cancer, and 60 with other tumours. Among them, 42.7% and the disease control rate (DCR) was 81.6%.

Doctors 147
article thumbnail

Pauline’s Superhero Story

KIF1A

So the pediatrician doctor requested the first cranial tomography, which also gave a normal result. One day later, we arrived at the hospital. A cheek swab DNA test was performed at the hospital, which also resulted as normal. Treatment is within reach, but there are two obstacles in our way: time and money. You can help.

Doctors 52
article thumbnail

Largest-ever genetic study of epilepsy finds possible therapeutic targets

Broad Institute

Largest-ever genetic study of epilepsy finds possible therapeutic targets By Ari Navetta October 3, 2024 Breadcrumb Home Largest-ever genetic study of epilepsy finds possible therapeutic targets Scientists have uncovered new genetic links to different types of epilepsy, which could lead to more tailored treatments.

72